Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Haggar, F. A. & Boushey, R. P. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 22, 191–197 (2009).
2. Marshall, J. L. et al. Adjuvant Therapy for Stage II and III Colon Cancer: Consensus Report of the International Society of Gastrointestinal Oncology. Gastrointest Cancer Res 1, 146–154 (2007).
3. Hagan, S., Orr, M. C. & Doyle, B. Targeted therapies in colorectal cancer-an integrative view by PPPM. EPMA J 4, 3 (2013).
4. Tournigand, C. et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22, 229–237 (2004).
5. Tsavdaridis, D. et al. Weekly oxaliplatin (OXA), 5-fluorouracil (FU) and leucovorin (LV) as first line treatment for advanced colorectal cancer (CRC) -A phase II study. J Clin Oncol 22, 3712 (2004).
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献